Fractures in the prodromal period of Parkinson disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 6, 2019
- Accepted in final form December 2, 2019
- First Published April 28, 2020.
Article Versions
- Previous version (April 28, 2020 - 12:44).
- You are viewing the most recent version of this article.
Author Disclosures
- Alejandra Camacho-Soto, MD,
- Anat Gross, MS,
- Susan Searles Nielsen, PhD,
- Anna N. Miller, MD,
- Mark N. Warden, MS,
- Amber Salter, PhD and
- Brad A. Racette, MD
- Alejandra Camacho-Soto, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Funding source: Rehabilitation Medicine Scientist Training Program (RMSTP) Fellowship NIH K12 Grant number: 5K12 HD001097-19 Role: PI/Fellow Years: 2015-2017
Funding source: Washington University School of Medicine Faculty Diversity Scholar Award Role: PI Years: 2018-2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anat Gross, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Susan Searles Nielsen, PhD,
NONE
NONE
NONE
(1) International Journal of Molecular Epidemiology and Genetics, Associate Board Member, 2012-present.
(1) Provisional patent application submitted for methods of lowering the risk for developing a neurodegenerative disease.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH-NIEHS, R01ES025991 and R01ES025991-O2S1, Co- Investigator, 2015-present, (2) NIH-NIEHS, R01ES021488, Data Analyst, 2014-present, (3) NIH-NIEHS, R21ES024120, 2014- 2016, (4) NIH-NIEHS, R01ES017462, Data Analyst, 2013-2015, (5) NIH-NIEHS, P42ES004696, Data Analyst, 2010-2014, (6) NIH-NIEHS, R01 ES026891, Co-Investigator, (7) NIH-NIEHS, K01ES028295, 2018-present, PI.
NONE
(1) Michael J. Fox Foundation, (2) American Parkinson Disease Association
NONE
NONE
NONE
NONE
NONE
NONE
- Anna N. Miller, MD,
NONE
NONE
NONE
Journal of Orthopaedic Trauma associate editor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Bonesupport
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mark N. Warden, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH K24ES017765, Analyst.
NONE
(1) Michael J. Fox Foundation, (2) American Parkinson Disease Association
NONE
NONE
NONE
NONE
NONE
NONE
- Amber Salter, PhD and
NONE
NONE
NONE
Circulation:Cardiovascular Imaging, 2018-2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brad A. Racette, MD
National Advisory Environmental Health Sciences Council
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
All the below are multi-center clinical trials: Allergan Teva Pharmaceuticals Civitas Therapeutics Ipsen US World Meds
NIH R01ES025991 (PI-Racette) 7/1/2015  6/30/2020 ÂMotor and Cognitive Health Outcomes in a Mn-Exposed African Community K24 NS060825 (PI-Racette) 4/1/2009  6/30/20 ÂEpidemiology and Biomarkers of Parkinsonism in Welders R01ES025991-02S1 (Racette) 05/01/2017  10/31/2020 ÂVirtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) R01ES026891 (PI-Racette) 9/1/2017 - 8/31/2022 ÂManganese-Induced Neurotoxic Effects Research in South Africa (MINERS) R01ES029524 (PI- Criswell) 04/01/19  03/31/24 Novel PET Markers of Cognitive Impairment in Manganese Neurotoxicity R01ES030937-S1(PI-Tjalkens) 08/01/2019-07/31/22 Encephalitic viral infection and susceptibility to dopaminergic neurotoxins ROH01166 (PI-Checkoway) 07/01/2019-06/30/23 Manganese-Related Motor and Cognitive Toxicity Among Professional Welders
Hope Center for Neurologic Disorders (PI-Racette) 1/1/2019-12/31/2021 ÂIdentification of Repurposed Prescription Medications as Neuroprotective
Michael J. Fox Foundation American Parkinson Disease Association
NONE
NONE
NONE
NONE
NONE
Johnson and Bell, retained expert, 2019
- From the Departments of Neurology (A.C.-S., A.G., S.S.N., M.N.W., B.A.R.) and Orthopedic Surgery (A.N.M.) and Division of Biostatistics (A.S.), Washington University School of Medicine, St. Louis, MO; and School of Public Health, Faculty of Health Sciences (B.A.R.), University of the Witwatersrand, Johannesburg, South Africa.
- Correspondence
Dr. Racette racetteb{at}neuro.wustl.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan